Evidence map›Paper›PMID 29146941›Full record

ArticleScientific reports2017

Developmental excitatory-to-inhibitory GABA-polarity switch is disrupted in 22q11.2 deletion syndrome: a potential target for clinical therapeutics.

Hayder Amin, Federica Marinaro, Davide De Pietri Tonelli, Luca Berdondini

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. GABA system as the cause and effect in early development.Neuroscience and biobehavioral reviews · 2024
    Review
  14. Article
  15. Atypical cortical networks in children at high-genetic risk of psychiatric and neurodevelopmental disorders.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Frontiers in psychiatry · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Hayder AminNets3 Laboratory, Department of Neuroscience and Brain Technologies (NBT), Fondazione Istituto Italiano di Tecnologia (IIT), Via Morego 30, 16163, Genoa, Italy. hayder.amin@iit.it.ORCID 0000-0002-6515-2991
Federica MarinaroNeurobiology of miRNA Laboratory, Department of Neuroscience and Brain Technologies (NBT), Fondazione Istituto Italiano di Tecnologia (IIT), Via Morego 30, 16163, Genoa, Italy.ORCID 0000-0001-6609-1134
Davide De Pietri TonelliNeurobiology of miRNA Laboratory, Department of Neuroscience and Brain Technologies (NBT), Fondazione Istituto Italiano di Tecnologia (IIT), Via Morego 30, 16163, Genoa, Italy.ORCID 0000-0001-9537-8900
Luca BerdondiniNets3 Laboratory, Department of Neuroscience and Brain Technologies (NBT), Fondazione Istituto Italiano di Tecnologia (IIT), Via Morego 30, 16163, Genoa, Italy.ORCID 0000-0001-9521-2812
Italian Institute of Technology · ITThe Gurdon Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Individuals with 22q11.2 microdeletion syndrome (22q11.2 DS) show cognitive and behavioral dysfunctions, developmental delays in childhood and risk of developing schizophrenia and autism. Despite extensive previous studies in adult animal models, a possible embryonic root of this syndrome has not been determined. Here, in neurons from a 22q11.2 DS mouse model (Lgdel

Indexed as

Molecular Targeted TherapyAnimalsBumetanideDiGeorge SyndromeDisease Models, Animalgamma-Aminobutyric AcidHippocampusMice, Inbred C57BLNerve NetNerve Tissue ProteinsNeural InhibitionNeuritesNeuronal PlasticityBumetanidegamma-Aminobutyric AcidNerve Tissue Proteins

Identifiers

PMID29146941
PMCPMC5691208
OpenAlexW2767295952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.